Familial pleuropulmonary blastoma in Australia

Siobhan F Cross1, Susan Arbuckle, John R Priest

  • 1Department of Oncology, The Children's Hospital at Westmead, Sydney, Australia. sbhn.f.cross@gmail.com

Pediatric Blood & Cancer
|October 29, 2010
PubMed

Insights

Three Australian children with pleuropulmonary blastoma (PPB) had family histories of various childhood tumors. These cases highlight a familial cancer syndrome linked to DICER1 mutations, emphasizing thorough family medical history reviews.

Area of Science:

  • Pediatric Oncology
  • Genetics
  • Pathology

Background:

  • Pleuropulmonary blastoma (PPB) is a rare pediatric lung tumor.
  • Familial cancer predisposition syndromes can involve multiple tumor types.
  • Genetic factors, such as DICER1 mutations, are implicated in some familial cancer syndromes.

Observation:

  • Three Australian children diagnosed with pleuropulmonary blastoma (PPB) were identified.
  • Each patient had a family history of diverse childhood malignancies, including PPB, cystic nephroma, and ovarian tumors.
  • Two patients had additional concurrent or subsequent malignancies, including rhabdomyosarcoma and other lung tumors.

Findings:

  • Detailed family medical histories revealed a pattern of inherited tumors across generations.
  • Archived pathology slides allowed for retrospective diagnosis confirmation.
  • The observed tumor spectrum suggests a pleiotropic familial cancer predisposition syndrome.

Implications:

  • These cases underscore the critical importance of comprehensive family medical history in diagnosing rare pediatric cancers.
  • The findings support the role of heterozygous DICER1 mutations in a familial cancer syndrome associated with PPB and other tumors.
  • Early identification of this syndrome can potentially improve patient management and genetic counseling.